We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Iconic Labs Plc | LSE:ICON | London | Ordinary Share | GB00BRBJ3P08 | ORD GBP0.0001 |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Health & Allied Services,nec | 4.77M | 0.4273 | 0.12 | 558.07k |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
- | O | 0 | 5.00 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
31/10/2024 | 15:57 | UK RNS | Iconic Labs PLC Full Year Results for the Year ended 30 June 2024 |
09/9/2024 | 06:00 | UK RNS | Iconic Labs PLC Waiver of Event of Default |
10/7/2024 | 16:21 | ALNC | Iconic Labs Chief Executive Brad Taylor steps down after three years |
10/7/2024 | 15:22 | UK RNS | Iconic Labs PLC Board Changes |
28/3/2024 | 14:35 | ALNC | EARNINGS AND TRADING: 888 advances US exit; Arrow ups reserve estimate |
28/3/2024 | 07:00 | UK RNS | Iconic Labs PLC Interim Results |
11/3/2024 | 13:52 | ALNC | Iconic Labs signs heads of terms deal to acquire ITS |
11/3/2024 | 12:00 | UK RNS | Iconic Labs PLC Heads of Terms Signed |
29/2/2024 | 07:00 | UK RNS | Iconic Labs PLC Total Voting Rights |
29/2/2024 | 07:00 | UK RNS | Iconic Labs PLC Suspension of Trading |
Iconic Labs (ICON) Share Charts1 Year Iconic Labs Chart |
|
1 Month Iconic Labs Chart |
Intraday Iconic Labs Chart |
Date | Time | Title | Posts |
---|---|---|---|
10/11/2024 | 16:19 | *** ICONIC LABS *** | 3,572 |
24/10/2024 | 11:53 | Iconic Labs PLC | 428 |
23/4/2024 | 06:58 | Different World MIA | 784 |
11/4/2023 | 11:23 | New beginning | 9,342 |
21/2/2023 | 11:47 | ICONIC LABS - New media and technology business | 20,595 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|
Top Posts |
---|
Posted at 21/11/2024 08:20 by Iconic Labs Daily Update Iconic Labs Plc is listed in the Health & Allied Services,nec sector of the London Stock Exchange with ticker ICON. The last closing price for Iconic Labs was 5p.Iconic Labs currently has 11,161,483 shares in issue. The market capitalisation of Iconic Labs is £558,074. Iconic Labs has a price to earnings ratio (PE ratio) of 0.12. This morning ICON shares opened at - |
Posted at 20/10/2024 15:11 by wally27 Telegram group link for Icon... |
Posted at 14/10/2024 16:23 by 1mb So if I bought 10000 icon shares on the day of suspension at 5p that would've cost me £500. If the transaction is completed and the share price returns at £1.50 and it's 1:1 share allocation then that £500 would be worth £15000...does that really happen in these rto scenarios?Any examples you can reference? |
Posted at 14/10/2024 13:52 by 1mb Understand that the per share value may well be 50p or greater but the question then would be are original icon shares 1:1 relative to the newco.Just wondering if anyone had any examples of this type of scenario previously as until we hear the terms of the prospectus it's all just conjecture. |
Posted at 13/10/2024 08:55 by 1mb Anyone have experience of this kind of thing before?When/if the transaction is completed how is the valuation of ICON shares calculated in the resulting company. Is there any correlation to the suspended price valuation? |
Posted at 03/10/2024 16:01 by bionicdog I am the foremost authority on ICON , you know that. |
Posted at 06/9/2024 13:04 by oliversanvil ICON LSE Chat active today. |
Posted at 12/7/2024 12:20 by bionicdog PWhite73 2 Jul '21 - 11:25 - 675 of 34960 0 3 adt - "What makes anyone think this time it with will be any different" That's the £50 million question. This time I believe it will be different because we have at the helm Brad Taylor a Canadian businessman who has held genuine executive positions with real companies and genuinely wants to make a business out of ICON. There is a vast difference now from the Punch and Judy show we've all been watching for the past two years. Taken from Iconic's website. "Brad has a wealth of experience at the executive and board levels with public and private companies, and brings managerial, restructuring, financial, and legal expertise to Iconic Labs. He began his career as an attorney in Texas with law firms Akin Gump Strauss Hauer & Feld and Greenberg Traurig before moving on to private equity with Holland Park Capital. From there, he worked in Paris as the General Counsel and member of the Executive Committee of Orco Property Group. Working with Ott Ventures, Brad has started and managed numerous companies and real estate projects in various stages of growth. A Canadian citizen, he has a Bachelor of Commerce from McGill University, a JD from Baylor University School of Law, and an MBA from INSEAD." This guy is the business. Can you really say that for DS or JQ. |
Posted at 10/7/2024 15:25 by oliversanvil Iconic Labs PLC("Iconic" or the "Company") Board Changes Iconic Labs PLC (LSE: ICON) announces that after more than three years of serving as the CEO and a Director of the Company, Brad Taylor is stepping down from all positions with immediate effect. The Company would like to thank Mr Taylor for his expertise, dedication and professionalism in successfully leading the Company through a complex period of restructuring that included exiting the Company from administration through a Company Voluntary Arrangement (CVA), lifting the suspension of trading on the London Stock Exchange, and entering into negotiations and Heads of Terms with reverse takeover (RTO) target, ITS Holdings 2023 Ltd. The Company also announces the appointment of John Farquharson (aged 47) as Interim CEO and Director with immediate effect. Mr Farquharson has held senior finance roles within the Tavistock Group of companies since 2010 and currently serves as Head of Finance at Ultimate Finance Group Ltd. He graduated from the University of Aberdeen in 1999 with an MA in Accountancy and German following which he worked at PwC from 1999-2004 where he qualified as a chartered accountant in 2002. He is a member of the Institute of Chartered Accountants of Scotland (ICAS) and the Chartered Governance Institute UK and Ireland. |
Posted at 13/10/2023 14:29 by endeavor2 Liar pwhite read the RNS and stop tellling lies.RNS Number : 0919Q Iconic Labs PLC 13 October 2023 13 October 2023 Iconic Labs PLC ("Iconic" or the "Company") Announcement of the Completion of CVA Iconic Labs PLC (LSE: ICON) is pleased to announce that the Creditors Voluntary Arrangement ("CVA") has been completed and the relevant documents have been filed at and accepted by Companies House. Brad Taylor, Chief Executive Officer of Iconic Labs, commented: "The successful completion of the CVA marks an important step towards Iconic Labs' financial stability. Now that the CVA is discharged, Iconic Labs has removed historic debts and is well positioned to progress with growth opportunities and focus on its strategic goals. "We look forward to updating shareholders and the market on our further activity in due course." - Ends - |
Posted at 13/10/2023 14:16 by endeavor2 RNS Number : 0919QIconic Labs PLC 13 October 2023 13 October 2023 Iconic Labs PLC ("Iconic" or the "Company") Announcement of the Completion of CVA Iconic Labs PLC (LSE: ICON) is pleased to announce that the Creditors Voluntary Arrangement ("CVA") has been completed and the relevant documents have been filed at and accepted by Companies House. Brad Taylor, Chief Executive Officer of Iconic Labs, commented: "The successful completion of the CVA marks an important step towards Iconic Labs' financial stability. Now that the CVA is discharged, Iconic Labs has removed historic debts and is well positioned to progress with growth opportunities and focus on its strategic goals. "We look forward to updating shareholders and the market on our further activity in due course." - Ends - So who do you believe a regulated company on the main market of the LSE or the liar pwhite ? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions